Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(6):152-159. doi: 10.17116/jnevro2019119061152.
[Nā ʻatikala ma ka Lūkini; Loaʻa ʻo Abstract ma ka Lūkini mai ka mea hoʻopuka]
Hōʻuluʻulu Manaʻo
Wahi a ka ʻikepili kuʻikahi o WHO, pono e hoʻokomo pū ʻia ka maʻi pīpī, me ke ʻano o ka hoʻowalewale pūnaewele (IA) i ka ʻāpana 'Impulsive disorders and behavioral addicts' o ICD-11. Hōʻike nā noiʻi heluna kanaka ma USA a me ʻEulopa i ka laha o IA mai 1.5 a i ka 8.2%, a ma nā ʻāina o Hikina Hema ʻo Asia hiki i 20-30% i waena o ka poʻe ʻōpio. Ke hāpai nei kēia mau mea āpau i nā nīnau e pili ana i ka hoʻomohala ʻana o nā ala maʻamau i ka mālama ʻana a me ka hoʻoponopono ʻana o kēia maʻi. Uhi ʻia ka loiloi i nā hoʻokokoke ʻana a me nā hana lāʻau ʻole. Ua hoʻolaʻa ʻia kekahi mau noiʻi a me nā lāʻau lapaʻau i nā hana lāʻau lapaʻau no ka mālama ʻana iā IA, me ka hoʻohana kūleʻa ʻia o nā antidepressants e like me escitalopram, clomipramine, a me bupropion. Aia kekahi ʻikepili e pili ana i ka maikaʻi o ka quetiapine, clonazepam, naltrexone a me methylphenidate. Ma ka laulaha, ua kaupalena ʻia ka noiʻi ʻana i nā hemahema o ke ʻano hana, me nā liʻiliʻi o ka laʻana, ka nele o nā pūʻulu kāohi a pēlā aku. No ke ʻano lāʻau ʻole pharmacological a psychotherapeutic, ʻo ia hoʻi, ʻo ka cognitive-behavioral therapy (CBT) ka mea i aʻo nui ʻia. Hoʻomohala ʻia nā papahana kūikawā CBT ma luna o nā keiki a me nā ʻōpio. Ma waho aʻe o ka CBT, ua hoʻohana ʻia nā hana psychotherapeutic ʻē aʻe no ka hoʻoponopono ʻana o IA: reality therapist, Internet inter intervensi, kaʻae ʻana a me ke kuleana kuleana, a me ka ohana therapy, a me nā ʻano hana paʻakikī. I nā ʻāina he nui i hoʻokumu ʻia nā kahua hoʻomoana lapaʻau (e laʻa me nā haʻuki a i ʻole nā hana waho ʻē aʻe) no nā ʻōpio me IA. Pono e aʻo hou i ka hana e hoʻomohala i nā ala lapaʻau a me ka hoʻohālikelike diagnostic o IA.
KEYWORDS: Pākuʻi Pūnaewele; lui kikowaena hoʻomāneʻe; lāʻauʻaleʻa; psychotherapy
PMID: 31407696
;